Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Crossbow Therapeutics
1030 Massachusetts Avenue
Cambridge, MA 02138
Education & Training
Brigham and Women's HospitalPost-Doctoral Fellowship, 2003 - 2008- Brigham and Women's HospitalFellowship, Hematopathology, 2001 - 2002
- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1999 - 2001
Stony Brook University Health Sciences Center School of MedicineClass of 1999
Stony Brook University/Cold Spring Harbor LaboratoryPhD, Molecular Genetics and Microbiology, 1993 - 1997
Certifications & Licensure
MA State Medical License 2002 - 2025- American Board of Pathology Anatomic Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 10 citationsSRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.Michael C Warren, Stephan Matissek, Matthew Rausch, Marisella Panduro, R J Hall
Immunohorizons. 2023-05-01 - 33 citationsThe Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a.Marisa O. Peluso, Ammar Adam, Caroline M. Armet, Li Zhang, O'connor Rachel W
Journal for Immunotherapy of Cancer. 2020-04-01 - 102 citationsPrevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth.Siyuan Xia, Ruiting Lin, Lingtao Jin, Liang Zhao, Hee-Bum Kang
Cell Metabolism. 2017-02-07
Grant Support
- Murine Models Of Activated FLT3 Receptor Tyrosine KinaseNational Cancer Institute2006–2007
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
